Clinical pharmacist intervention to improve medication safety for hip fracture patients through secondary and primary care settings: a nonrandomised controlled trial

[1]  T. Pressat-Laffouilhère,et al.  Clinical Pharmacist Intervention Reduces Potentially Inappropriate Prescriptions in a Geriatric Perioperative Care Unit Dedicated to Hip Fracture , 2022, Gerontology.

[2]  K. Halvorsen,et al.  Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (The IMMENSE study) – a randomized controlled trial , 2022, BMC Health Services Research.

[3]  C. Tarrant,et al.  Polypharmacy and continuity of care: medicines optimisation in the era of multidisciplinary teams , 2022, BMJ Quality & Safety.

[4]  É. A. Silveira,et al.  Risk factors for potentially inappropriate medication use in older adults: a cohort study , 2022, International Journal of Clinical Pharmacy.

[5]  E. Stensland,et al.  Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018 , 2022, The bone & joint journal.

[6]  V. Moore,et al.  Effect of pharmacy-led interventions during care transitions on patient hospital readmission: A systematic review. , 2022, Journal of the American Pharmacists Association : JAPhA.

[7]  M. Ekstedt,et al.  What is needed for continuity of care and how can we achieve it? – Perceptions among multiprofessionals on the chronic care trajectory , 2022, BMC Health Services Research.

[8]  R. D. Andersen,et al.  Development and initial validation of MedHipPro-Q: a questionnaire assessing medication management of hip fracture patients in different care settings , 2022, BMC Health Services Research.

[9]  C. Rioufol,et al.  How a Patient Personalised Clinical Pharmacy Programme Can Secure Therapeutic Care in an Orthogeriatric Care Pathway (5P Project)? , 2021, Clinical interventions in aging.

[10]  I. Reid,et al.  Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5‐Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open‐Label Extension of a Randomized Controlled Trial , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Ravensara S. Travillian,et al.  Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 , 2021, The Lancet. Healthy longevity.

[12]  J. Kanis,et al.  SCOPE 2021: a new scorecard for osteoporosis in Europe , 2021, Archives of Osteoporosis.

[13]  D. Shahian.  I-PASS handover system: a decade of evidence demands action , 2021, BMJ Quality & Safety.

[14]  K. Fushimi,et al.  Seasonality of mortality and in‐hospital complications in hip fracture surgery: Retrospective cohort research using a nationwide inpatient database , 2021, Geriatrics & gerontology international.

[15]  D. Bhattacharya,et al.  Barriers and facilitators to pharmacists integrating into the ward-based multidisciplinary team: A systematic review and meta-synthesis. , 2021, Research in social & administrative pharmacy : RSAP.

[16]  V. Halsteinli,et al.  Health care services and costs after hip fracture, comparing conventional versus standardised care: A retrospective study with 12-month follow-up. , 2021, Injury.

[17]  J. Bongaarts,et al.  United Nations Department of Economic and Social Affairs, Population Division World Family Planning 2020: Highlights, United Nations Publications, 2020. 46 p. , 2020 .

[18]  E. Skovlund,et al.  Effect of medicines management versus standard care on readmissions in multimorbid patients: a randomised controlled trial , 2020, BMJ Open.

[19]  I. Imran,et al.  Risk Factors Associated With Medication Errors Among Patients Suffering From Chronic Disorders , 2020, Frontiers in Public Health.

[20]  L. Nielsen,et al.  Prevalence of medication-related falls in 200 consecutive elderly patients with hip fractures: a cross-sectional study , 2020, BMC Geriatrics.

[21]  R. Marfella,et al.  Medication review versus usual care to improve drug therapies in hospitalised older patients admitted to internal medicine wards , 2020 .

[22]  E. Sims,et al.  Contamination in complex healthcare trials: the falls in care homes (FinCH) study experience , 2020, BMC Medical Research Methodology.

[23]  I. Reid,et al.  Ten years of very infrequent zoledronate therapy in older women: an open-label extension of a randomized trial. , 2020, The Journal of clinical endocrinology and metabolism.

[24]  G. Tell,et al.  Estimating the future burden of hip fractures in Norway. A NOREPOS study. , 2019, Bone.

[25]  A. Avery,et al.  Processing discharge summaries in general practice: a qualitative interview study with GPs and practice managers , 2019, BJGP open.

[26]  Cathy Ammerman,et al.  Potentially Inappropriate Medications in Older Adults: Deprescribing with a Clinical Pharmacist , 2018, Journal of the American Geriatrics Society.

[27]  E. Delgado-Silveira,et al.  Fall-risk increasing drugs and prevalence of polypharmacy in older patients discharged from an Orthogeriatric Unit after a hip fracture , 2018, Aging Clinical and Experimental Research.

[28]  A. Beckman,et al.  Effects of medication reviews on use of potentially inappropriate medications in elderly patients; a cross-sectional study in Swedish primary care , 2018, BMC Health Services Research.

[29]  T. Bertsche,et al.  A dual intervention in geriatric patients to prevent drug-related problems and improve discharge management , 2018, International Journal of Clinical Pharmacy.

[30]  J. Hallas,et al.  Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission: A Randomized Clinical Trial , 2018, JAMA internal medicine.

[31]  H. Lövheim,et al.  Effects of Pharmacists’ Interventions on Inappropriate Drug Use and Drug-Related Readmissions in People with Dementia—A Secondary Analysis of a Randomized Controlled Trial , 2018, Pharmacy.

[32]  B. Garcia,et al.  Quality of medication information in discharge summaries from hospitals: an audit of electronic patient records , 2017, International Journal of Clinical Pharmacy.

[33]  S. Kane-Gill,et al.  Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review , 2017, Research in social & administrative pharmacy : RSAP.

[34]  H. Sørensen,et al.  Hip Fracture, Comorbidity, and the Risk of Myocardial Infarction and Stroke: A Danish Nationwide Cohort Study, 1995–2015 , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  J. A. Roberts,et al.  The effect of pharmacists on ward rounds measured by the STOPP/START tool in a specialized geriatric unit , 2017, Journal of clinical pharmacy and therapeutics.

[36]  F. Leung,et al.  Seasonal Variation in Hip Fracture Mortality , 2017, Geriatric orthopaedic surgery & rehabilitation.

[37]  S. Peixoto,et al.  Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults , 2017, European Journal of Clinical Pharmacology.

[38]  O. Melander,et al.  Polypharmacy and adverse outcomes after hip fracture surgery , 2016, Journal of Orthopaedic Surgery and Research.

[39]  M. Piccart,et al.  Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist. , 2016, Journal of geriatric oncology.

[40]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.

[41]  Daniel J Brotman,et al.  Association between days to complete inpatient discharge summaries with all-payer hospital readmissions in Maryland. , 2016, Journal of hospital medicine.

[42]  S. Elmståhl,et al.  Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study , 2016, Clinical interventions in aging.

[43]  A. Rieutord,et al.  Medication at discharge in an orthopaedic surgical ward: quality of information transmission and implementation of a medication reconciliation form , 2016, International Journal of Clinical Pharmacy.

[44]  Joshua D. Brown,et al.  Predictive Validity of the Beers and Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States , 2016, Journal of the American Geriatrics Society.

[45]  Janne Kutschera Sund,et al.  Medication reconciliation of patients with hip fracture by clinical pharmacists , 2015, European journal of hospital pharmacy. Science and practice.

[46]  M. K. Javaid,et al.  Impact of hip fracture on hospital care costs: a population-based study , 2015, Osteoporosis International.

[47]  K. Viktil,et al.  Medication discrepancies revealed by medication reconciliation and their potential short-term and long-term effects: a Norwegian multicentre study carried out on internal medicine wards , 2015 .

[48]  J. McElnay,et al.  Integrated medicines management to medicines optimisation in Northern Ireland (2000–2014): a review , 2015 .

[49]  Leora I. Horwitz,et al.  Association of Discharge Summary Quality With Readmission Risk for Patients Hospitalized With Heart Failure Exacerbation , 2015, Circulation. Cardiovascular quality and outcomes.

[50]  D. Bhattacharya,et al.  Adherence to UK national guidance for discharge information: an audit in primary care. , 2014, British journal of clinical pharmacology.

[51]  I. Scott,et al.  Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis , 2014, BMJ Open.

[52]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[53]  Liv Johanne Wekre,et al.  Evaluation of implementation of clinical pharmacy services in Central Norway , 2013 .

[54]  S. Cummings,et al.  The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT) , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[55]  A. Skinner,et al.  Improving the Quality of Discharge Communication With an Educational Intervention , 2010, Pediatrics.

[56]  P. Romundstad,et al.  Incidence and seasonal variation in hip fracture incidence among elderly women in Norway. The HUNT Study. , 2010, Bone.

[57]  J. Hanlon,et al.  Potentially Inappropriate Medications and Risk of Hospitalization in Retirees , 2010, Drugs & aging.

[58]  D. Moher,et al.  CorrespondenceCONSORT 2010 Statement : updated guidelines for reporting parallel group randomised trials , 2010 .

[59]  P. Höglund,et al.  Improved quality in the hospital discharge summary reduces medication errors—LIMM: Landskrona Integrated Medicines Management , 2009, European Journal of Clinical Pharmacology.

[60]  S. Boonen,et al.  Zoledronic acid and clinical fractures and mortality after hip fracture. , 2007, The New England journal of medicine.

[61]  J. McElnay,et al.  An innovative approach to integrated medicines management. , 2007, Journal of evaluation in clinical practice.

[62]  Didier Pittet,et al.  Assuring Medication Accuracy at Transitions in Care , 2007 .

[63]  D. Baker,et al.  Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. , 2007, JAMA.

[64]  Rafael Perera,et al.  Graphical method for depicting randomised trials of complex interventions , 2007, BMJ : British Medical Journal.

[65]  Pratibha Rao,et al.  Assessing Quality and Efficiency of Discharge Summaries , 2005, American journal of medical quality : the official journal of the American College of Medical Quality.

[66]  N. Cockayne,et al.  A Quality Use of Medicines program for continuity of care in therapeutics from hospital to community , 2002, The Medical journal of Australia.

[67]  O. Johnell,et al.  Consequences of a hip fracture: A prospective study over 1 year , 1993, Osteoporosis International.

[68]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[69]  N. Shah,et al.  Effect of an Integrated Clinical Pharmacist on the Drivers of Provider Burnout in the Primary Care Setting , 2021, The Journal of the American Board of Family Medicine.

[70]  Aleš Bourek,et al.  Task Shifting and Health System Design : Report of the Expert Panel on effective ways of investing in Health (EXPH) , 2019 .

[71]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Trials.

[72]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[73]  A Heinonen,et al.  Epidemiology of hip fractures. , 1996, Bone.

[74]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.